We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+7.61%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+258.3%
AUM
$1.4B
AUM Growth
+$68.9M
Cap. Flow
-$31.6M
Cap. Flow %
-2.25%
Top 10 Hldgs %
26.53%
Holding
282
New
16
Increased
76
Reduced
95
Closed
4

Sector Composition

Rank Sector Weight
1 Technology 22.46%
2 Healthcare 15.24%
3 Financials 8.38%
4 Industrials 8.09%
5 Consumer Discretionary 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CL icon
101
Colgate-Palmolive
CL
$74.4B
$2.68M 0.19%
32,941
-370
-1% -$30.3K
ITW icon
102
Illinois Tool Works
ITW
$84.5B
$2.64M 0.19%
11,812
-100
-0.8% -$22.9K
ALC icon
103
Alcon
ALC
$35B
$2.58M 0.18%
36,679
-600
-2% -$42.7K
MDLZ icon
104
Mondelez International
MDLZ
$79.9B
$2.55M 0.18%
40,825
+31
+0.1% +$1.91K
TT icon
105
Trane Technologies
TT
$106B
$2.47M 0.18%
13,430
XOM icon
106
ExxonMobil
XOM
$634B
$2.44M 0.17%
38,760
-460
-1% -$27.5K
HUBB icon
107
Hubbell
HUBB
$27.2B
$2.34M 0.17%
12,506
AMGN icon
108
Amgen
AMGN
$222B
$2.27M 0.16%
9,294
ADI icon
109
Analog Devices
ADI
$190B
$2.26M 0.16%
13,146
+366
+3% +$58.6K
AXP icon
110
American Express
AXP
$230B
$2.25M 0.16%
13,613
-50
-0.4% -$7.83K
DEO icon
111
Diageo
DEO
$53.6B
$2.24M 0.16%
11,696
PM icon
112
Philip Morris
PM
$295B
$2.21M 0.16%
22,282
ILMN icon
113
Illumina
ILMN
$28.4B
$2.19M 0.16%
4,761
+206
+5% +$83K
LLY icon
114
Eli Lilly
LLY
$1.06T
$2.13M 0.15%
9,276
-25
-0.3% -$5.02K
GILD icon
115
Gilead Sciences
GILD
$165B
$2.06M 0.15%
29,910
-1,225
-4% -$81.8K
WELL icon
116
Welltower
WELL
$171B
$2.03M 0.15%
24,449
+161
+0.7% +$12.3K
IWM icon
117
iShares Russell 2000 ETF
IWM
$83B
$1.91M 0.14%
8,334
VGIT icon
118
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.7B
$1.88M 0.13%
27,676
+2,224
+9% +$151K
VV icon
119
Vanguard Morningstar Large-Cap ETF
VV
$54.3B
$1.86M 0.13%
9,259
+215
+2% +$42K
ORCL icon
120
Oracle
ORCL
$423B
$1.85M 0.13%
23,834
-214
-0.9% -$16.8K
BMY icon
121
Bristol-Myers Squibb
BMY
$132B
$1.85M 0.13%
27,652
-200
-0.7% -$13K
D icon
122
Dominion Energy
D
$59.3B
$1.84M 0.13%
25,070
-2,155
-8% -$166K
TYL icon
123
Tyler Technologies
TYL
$12.8B
$1.84M 0.13%
4,070
+180
+5% +$76.5K
ROOT icon
124
Root
ROOT
$798M
$1.83M 0.13%
+9,406
New +$1.78M
XYZ
125
Block Inc
XYZ
$47.5B
$1.83M 0.13%
7,505

Similar funds

Boston Family Office's Q2 2021 Portfolio in Review

As of Q2 2021, Boston Family Office held 282 positions worth $1.4B, up 5.2% from $1.33B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Boston Family Office's Q2 2021 filing shows 16 new, 76 increased, 95 reduced and 4 closed positions. Its largest new stake was Root: 9,406 shares worth $1.83M. The largest sale was Sherwin-Williams, an estimated $14.1M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Boston Family Office's largest Q2 2021 buy was Root: 9,406 shares worth $1.83M.
  • Boston Family Office added most to S&P Global in Q2 2021, an estimated $3.04M increase.
  • Boston Family Office's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $14.1M.
  • Boston Family Office fully exited Golar LNG in Q2 2021, selling an estimated $3.18M.
  • Boston Family Office's ten largest holdings make up 27% of its $1.4B portfolio in Q2 2021.
  • Boston Family Office opened 16 new positions and closed 4 in Q2 2021.
  • Boston Family Office's portfolio value rose 5.2% quarter-over-quarter to $1.4B.

Based on Boston Family Office's 13F filing for Q2 2021, filed 12 Aug 2021.